Assessing Significance of Cognitive Assessments for Diagnosing Alzheimer’s Disease with Fuzzy-Rough Feature Selection

  • Conference paper
  • First Online:
Advances in Computational Intelligence Systems (UKCI 2021)

Abstract

Research in dementia diagnosis typically involves a range of data modalities and also, the use of cognitive assessments, aiming at the development of approaches that are non-invasive, time-saving and economical. Given the existing diversity of prevalent cognitive assessment factors it is useful to assess and exploit the effectiveness of such cognitive features, while working towards the establishment of a methodology for making informed choice of such factors in practical use. As an initial approach, this paper employs the powerful Fuzzy-Rough Feature Selection (FRFS) technique to support such an analysis, by varying the underlying similarity functions and search strategies employed by FRFS. Evaluated on a benchmark from the renowned Alzheimer’s Disease Neuroimaging Initiative repository, experimental results demonstrate the significance and predictive capabilities of different cognitive assessments in working with a variety of popular classifiers.

Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organisation, Dementia (2019). https://www.who.int/news-room/fact-sheets/detail/dementia

  2. Kour, H., Manhas, J., Sharma, V.: Evaluation of adaptive neuro-fuzzy inference system with artificial neural network and fuzzy logic in diagnosis of Alzheimer Disease. In: 6th International Conference on Computing for Sustainable Global Development, pp. 1041–1046. IEEE (2019)

    Google Scholar 

  3. Young, D.W.: What does an MRI scan cost? Healthc. Financ. Manag.69(11), 46–49 (2015)

    Google Scholar 

  4. NHS: Guide to NHS waiting times in England - NHS (2019). https://www.nhs.uk/using-the-nhs/nhs-services/hospitals/guide-to-nhs-waiting-times-in-england/

  5. Er, F., Iscen, P., Sahin, S., Çinar, N., Karsidag, S., Goularas, D.: Distinguishing age-related cognitive decline from dementias: a study based on machine learning algorithms. J. Clin. Neurosci. (2017)

    Google Scholar 

  6. Zhu, F., et al.: Analyze informant-based questionnaire for the early diagnosis of senile dementia using deep learning. IEEE J. Transl. Eng. Health Med. 8 (2020)

    Google Scholar 

  7. Lee, G.G., Huang, P.W., **e, Y.R., Pai, M.C. : Classification of Alzheimer’s disease, mild cognitive impairment, and cognitively normal based on neuropsychological data via supervised learning. In: IEEE Region 10 Annual International Conference, Proceedings/TENCON, pp. 1808–1812 (October 2019)

    Google Scholar 

  8. Chen, T., et al.: A decision tree-initialised neuro-fuzzy approach for clinical decision support. Artif. Intell. Med. 111, 101986 (2020)

    Google Scholar 

  9. Chen, T., Antoniou, G., Adamou, M., Tachmazidis, I., Su, P.: Automatic diagnosis of attention deficit hyperactivity disorder using machine learning. Appl. Artif. Intell. 1–13 (2021)

    Google Scholar 

  10. Jensen, R., Shen, Q.: New approaches to fuzzy-rough feature selection. Fuzzy Syst. IEEE Trans. 17(4), 824–838 (2009)

    Article  Google Scholar 

  11. Jensen, R., Shen, Q.: Fuzzy-rough sets assisted attribute selection. Fuzzy Syst. IEEE Trans. 15(1), 73–89 (2007)

    Google Scholar 

  12. Chouchoulas, A., Shen, Q.: Rough set-aided keyword reduction for text categorization. Appl. Artif. Intell. 15(9), 843–873 (2001)

    Article  Google Scholar 

  13. Sheehan, B.: Assessment scales in dementia. Ther. Adv. Neurol. Disord. 5(6), 349–358 (2012)

    Article  Google Scholar 

  14. Chen, T., Shang, C., Su, P., Shen, Q.: Induction of accurate and interpretable fuzzy rules from preliminary crisp representation. Knowl.-Based Syst. 146, 152–166 (2018)

    Article  Google Scholar 

  15. Eibe, F., Hall, M.A., Witten, I.H.: The WEKA Workbench. Online Appendix for Data Mining: Practical Machine Learning Tools and Techniques, Fourth Edn. Morgan Kaufmann, Burlington (2016)

    Google Scholar 

  16. Shang, C., Barnes, D., Shen, Q.: Facilitating efficient mars terrain image classification with fuzzy-rough feature selection. Int. J. Hybrid Intell. Syst. 8(1), 3–13 (2011)

    Google Scholar 

  17. Chen, T., Shang, C., Yang, J., Li, F., Shen, Q.: A new approach for transformation-based fuzzy rule interpolation. IEEE Trans. Fuzzy Syst. 28(12), 3330–3344 (2020)

    Article  Google Scholar 

Download references

Acknowledgements

Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.

This work was partly supported by grants from the National Natural Science Foundation of China (No. 61906181 and 72001032), and partly by the Strategic Partner Acceleration Award (80761- AU201) under the S\(\hat{\text {e}}\)r Cymru II programme, UK.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Tianhua Chen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Chen, T. et al. (2022). Assessing Significance of Cognitive Assessments for Diagnosing Alzheimer’s Disease with Fuzzy-Rough Feature Selection. In: Jansen, T., Jensen, R., Mac Parthaláin, N., Lin, CM. (eds) Advances in Computational Intelligence Systems. UKCI 2021. Advances in Intelligent Systems and Computing, vol 1409. Springer, Cham. https://doi.org/10.1007/978-3-030-87094-2_40

Download citation

Publish with us

Policies and ethics

Navigation